JPMorgan Chase & Co. Acquires 147,784 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

JPMorgan Chase & Co. lifted its position in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 175.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 231,957 shares of the company's stock after purchasing an additional 147,784 shares during the quarter. JPMorgan Chase & Co. owned 0.47% of Nu Skin Enterprises worth $1,710,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Canada Pension Plan Investment Board bought a new position in shares of Nu Skin Enterprises in the second quarter valued at about $47,000. Dark Forest Capital Management LP bought a new position in shares of Nu Skin Enterprises in the second quarter worth about $106,000. Covestor Ltd lifted its position in shares of Nu Skin Enterprises by 110.9% during the third quarter. Covestor Ltd now owns 10,140 shares of the company's stock worth $75,000 after purchasing an additional 5,333 shares in the last quarter. Gladius Capital Management LP bought a new stake in shares of Nu Skin Enterprises during the third quarter valued at approximately $77,000. Finally, Versor Investments LP acquired a new stake in shares of Nu Skin Enterprises in the third quarter valued at approximately $86,000. Institutional investors and hedge funds own 82.84% of the company's stock.

Nu Skin Enterprises Trading Up 1.3 %

NUS traded up $0.09 during trading on Thursday, reaching $7.12. 588,492 shares of the company's stock were exchanged, compared to its average volume of 897,421. The company's fifty day moving average price is $7.17 and its 200-day moving average price is $7.89. The firm has a market capitalization of $354.08 million, a PE ratio of -3.44 and a beta of 1.19. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.95 and a fifty-two week high of $19.30. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.20 and a current ratio of 1.93.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.03). Nu Skin Enterprises had a positive return on equity of 5.47% and a negative net margin of 5.81%. The company had revenue of $430.15 million for the quarter, compared to analyst estimates of $444.10 million. During the same quarter in the previous year, the firm posted $0.56 earnings per share. As a group, equities analysts forecast that Nu Skin Enterprises, Inc. will post 0.68 EPS for the current year.

Nu Skin Enterprises Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 11th. Stockholders of record on Friday, November 29th were given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.37%. The ex-dividend date was Friday, November 29th. Nu Skin Enterprises's dividend payout ratio is currently -11.59%.

Analyst Ratings Changes

Several research analysts have issued reports on NUS shares. Citigroup reduced their price objective on Nu Skin Enterprises from $11.50 to $6.75 and set a "neutral" rating on the stock in a report on Tuesday, October 22nd. DA Davidson cut their price target on Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating on the stock in a research note on Friday, December 20th. Finally, StockNews.com upgraded Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, November 11th.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.